Evid Invest
Who owns KYMRWhat KYMR owns — n/a

Who owns Kymera Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of KYMR from SEC Form 13F filings across 302 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 302 institutions disclosed 98.9M shares of Kymera Therapeutics, Inc. worth $11.07B — about 98.8% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

302

13F holders

$11.07B

value, 2026 filers

98.8%

of shares outstanding (98.9M sh)

51

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of KYMR's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC12.6M$1.41B0.1%12.6%+1.8%
2PRICE T ROWE ASSOCIATES INC /MD/8.7M$975.5M0.1%8.7%+22.7%
3BAKER BROS. ADVISORS LP8.7M$967.8M4.6%8.6%0.0%
4Avoro Capital Advisors LLC7.5M$835.6M8.6%7.5%0.0%
5BlackRock, Inc.5.8M$651.2M0.0%5.8%+5.2%
6T. Rowe Price Investment Management, Inc.5.7M$641.3M0.5%5.7%-8.3%
7BVF INC/IL3.9M$432.9M14.2%3.9%0.0%
8WELLINGTON MANAGEMENT GROUP LLP3.7M$414.4M0.1%3.7%+0.9%
9VANGUARD CAPITAL MANAGEMENT LLC3.0M$340.3M0.0%3%+3.8%
10VANGUARD PORTFOLIO MANAGEMENT LLC3.0M$333.0M0.0%3%-0.5%
11Atlas Venture Life Science Advisors, LLC2.8M$318.3M50.4%2.8%0.0%
12Siren, L.L.C.2.8M$311.3M7.4%2.8%-5.1%
13STATE STREET CORP2.6M$288.8M0.0%2.6%-5.6%
14GEODE CAPITAL MANAGEMENT, LLC1.9M$214.0M0.0%1.9%+5.4%
15GOLDMAN SACHS GROUP INC1.2M$135.1M0.0%1.2%+1.8%
16Capital Research Global Investors1.1M$126.4M0.0%1.1%-18.6%
17UBS Group AG1.0M$115.6M0.0%1%+2.6%
18CHARLES SCHWAB INVESTMENT MANAGEMENT INC886,951$99.2M0.0%0.9%+67.4%
19ALLIANCEBERNSTEIN L.P.819,071$91.6M0.0%0.8%-16.6%
20Driehaus Capital Management LLC808,098$90.3M0.6%0.8%-12.1%
21Merck & Co., Inc.772,165$86.3M10.5%0.8%0.0%
22FEDERATED HERMES, INC.747,432$83.6M0.1%0.7%-0.3%
23Holocene Advisors, LP721,687$80.7M0.2%0.7%+13.4%
24UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC702,329$78.5M0.0%0.7%-4.7%
25DIMENSIONAL FUND ADVISORS LP693,290$77.5M0.0%0.7%-7.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.